Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The SP & TR patients.

<< Previous

Bullboard Posts

Next >>

Comment by thadeushon May 07, 2023 12:40pm

220 Views

Post# 35435306

RE:The SP & TR patients.

Me not so smart and I'm not sure where TLT stands right now...my understanding is that we have the 360 day results and are waiting for the 450 day results before the FDA makes a decision. Is this correct? Do we have a ballpark day/month for the 450 day results for?

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?